nav-left cat-right
cat-right

International symposium “Stem Cell Transplan...

International symposium “Stem Cell Transplantation in Multiple Sclerosis: Sharing the Experience” will be held  on October 5th, 2009 in  Moscow, Russia. Symposuim Organizers are Pirogov National Medical Surgical Center, National Center for Research and Treatment of Autoimmune Diseases, Russian Cooperative Group for Cellular Therapy, New Jersey Center for Quality of Life and Health Outcomes Research. The...

CytRx Unveils Clinical Development Plan for Pipeli...

Names World-Renowned Cancer Drug Expert Dr. Joseph Rubinfeld as Chief Scientific Advisor LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (NASDAQ: CYTR) today unveiled its corporate strategy to focus its internal resources on the clinical development of oncology drug candidates tamibarotene and INNO-206, which the Company believes offer the greatest mix of near-term and medium-term...

MorphoSys and Galapagos Enter Alliance to Co-devel...

Combination of Proprietary Drug Targets and Unique Technologies to Create Range of New Therapeutic Antibodies MUNICH, GERMANY — (Marketwire) — 11/26/08 — MorphoSys AG (FSE: MOR; Prime StandardSegment, TecDAX) and Galapagos NV (Euronext: GLPG) announced today the launch of a long term co-development alliance aimed at discovering and developing antibody therapies based on novel modes of action in bone and...

The difficulties of Cushing’s syndrome

Diagnosing and treating Cushing’s syndrome is sometimes just as difficult as it was 70 years ago. For as long as it has been described, Cushing’s syndrome has presented physicians with a problem. Harvey Cushing first described it in 1932, and the diagnosis, differential diagnosis and treatment of Cushing’s have remained a major challenge for endocrinologists ever since. Though uncommon, it is...

Tepnel Expands Genetic Services Portfolio with Add...

MANCHESTER, United Kingdom & STAMFORD, Conn.–Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina’s iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This announcement marks the first anniversary of...

Seegene/Lab901 brings a New Detection Platform for...

Rockville, MD, and Edinburgh, Scotland, June 17, 2008:  Seegene and Lab901 today announced the availability of a novel automated multi-pathogen walk-away detection platform for European hospitals. Based on the Seeplex(R) multiplexing PCR system and ScreenTape(R)  gel electrophoresis detection system, this new Seeplex/ScreenTape detection platform will be introduced to clinical and research laboratories in 10...
Page 6 of 8« First...45678